-
Abstract Number: 2071
Self-Efficacy Contributes to Better Health Outcomes in Patients of Idiopathic Inflammatory Myopathies: Insights from the COVAD 3 Dataset
-
Abstract Number: 2072
Clinical and Laboratory Features Associated with Pulmonary Involvement in Patients with Inflamatory Myopathy
-
Abstract Number: 2073
Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison
-
Abstract Number: 2074
Experience on the Use of Obinutuzumab off Label in Patients with Refractory Idiopathic Inflammatory Myopathy
-
Abstract Number: 2075
A Retrospective Cohort Study Assessing Outcomes and Safety in Patients Receiving Low Dose vs High Dose Cyclophosphamide in Myositis Interstitial Lung Disease (ILD)
-
Abstract Number: 2076
Comparing the Efficacy of Conventional Immunosuppression and Rituximab in Anti-SRP Myositis: Insights from a Tertiary Care Centre Experience
-
Abstract Number: 2077
Comparison of Janus Kinase Inhibitors to Block the Type I and II Interferon Pathways in Human Myoblasts
-
Abstract Number: 2078
Increased RAGE Expression in Myositis
-
Abstract Number: 2079
Understanding Relapse Patterns in Anti-HMGCR Statin-induced IMNM: A Detailed Comparative Study
-
Abstract Number: 2080
HLA-DRB1*11:01 Association Differenciates Anti-hmgcr Immune-mediated Necrotizing Myopathy from Non-immune Mediated Statin Myotoxicity
-
Abstract Number: 2081
Proteomic Profiling of Urine Reveals Biomarker Candidates for Idiopathic Inflammatory Myopathies
-
Abstract Number: 2082
Different Clinical Phenotypes of Patients with Anti-synthetase Syndrome: Unsupervised Cluster Analysis in the CLASS Database
-
Abstract Number: 2083
A Novel Scoring System to Predict a Cancer Development in Patients with Idiopathic Inflammatory Myopathy
-
Abstract Number: 2084
Efficacy and Safety of a Step-down Regimen of Low Dosage of Glucocorticoids Combined with Early Administration of Synthetic or Biologic Immunosuppressants in Anti-synthetase Syndrome: A Pilot Study
-
Abstract Number: 2085
The Effects of Pioglitazone on Metabolic Dysregulation in Inclusion Body Myositis: An Open-Label Pilot Study
- « Previous Page
- 1
- …
- 138
- 139
- 140
- 141
- 142
- …
- 181
- Next Page »